Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL). (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17132
PubMed Identifier: 33010029
Publication URI: http://europepmc.org/abstract/MED/33010029
Type: Journal Article/Review
Volume: 192
Parent Publication: British journal of haematology
Issue: 1
ISSN: 0007-1048